Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric suit may help people with spinal cord injury walk better

NCT ID NCT07645144

Disease control Sponsor: Stichting Reade Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wearable suit that delivers small electrical pulses to leg muscles can improve walking speed in people with incomplete spinal cord injury. Participants first do standard treadmill training, then add the electrical stimulation suit for 20 sessions. The main goal is to see if the stimulation leads to faster walking compared to training without it.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
functional electrical stimulation (FES) via a wearable suit
What this could lead to
If it works, this could point toward a more effective way to improve walking ability in people with incomplete spinal cord injury.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The FES suit may not provide additional benefit over standard training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have a non-progressive chronic (\>1 yrs) incomplete SCI between C4 and T12 with an ASIA score of C or D. * Be at least 18 years of age. * Be able to take some steps (with assistive devices or in the bridge). * As part of the inclusion process, responsiveness to electrical stimulation will be assessed using a Compex electrical stimulator (Compex SP 4.0; Compex Medical SA, Switzerland) to ensure potential participant's respond well to ES, and to ensure that the sensitivity threshold is not reached before motor response in all target muscles. Exclusion Criteria: * Flaccid paralysis. * Musculoskeletal dysfunction, uncured fractures, contractures, pressure injuries, or infections that could impede the intended training. * Botox injections in the lower extremities during the last six months. * Women who are (planning to get) pregnant during the study period. * Implanted neurostimulator or stimulator of any kind that can have an influence on the safe use of ES. * Pacemaker, or other device, present in the body that prevents the safe use of ES. * Inability to communicate well or have cognitive disorders. * Currently being enrolled in another training study or participated in a training study in the previous six months. * Having an illness that has a high chance of preventing them to be able to perform the training at a sufficient frequency.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incomplete spinal cord injury (SCI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Incomplete spinal cord injury (SCI) Sci - spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Stichting Reade

    Amsterdam, 1054HW, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.